CPHI - CHINA PHARMA HOLDINGS, INC.
0.5617
-0.030 -5.323%
Share volume: 14,126
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$0.59
-0.03
-0.05%
View ratios
| Fiscal Date | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 11-13-2024 | 05-14-2025 | 08-14-2025 | 11-12-2025 | |
| Total revenue | 1.100 M | 1.136 M | 1.026 M | 756.217 K | |
| Cost of revenue | 1.618 M | 1.271 M | 1.115 M | 815.871 K | |
| Gross profit | -519.649 K | -136.061 K | -89.042 K | -59.654 K | |
| 73.82% | 34.56% | 33.00% | |||
| Operating expenses | 567.264 K | 623.880 K | 412.388 K | 543.189 K | |
| Selling general and admin | 479.654 K | 594.293 K | 542.126 K | 502.868 K | |
| Research and development | 87.610 K | 29.587 K | -129.738 K | 40.321 K | |
| Total expenses | 567.264 K | 623.880 K | 412.388 K | 568.491 K | |
| 9.98% | -33.90% | 37.85% | |||
| Operating income | -1.085 M | -758.618 K | -652.120 K | -628.145 K | |
| Ebit | -1.085 M | -758.618 K | -652.120 K | -628.145 K | |
| Pretax income | -1.118 M | -785.572 K | -528.367 K | -651.482 K | |
| -29.73% | -32.74% | 23.30% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -1.118 M | -785.572 K | -528.367 K | -651.482 K | |
| 29.73% | 32.74% | -23.30% |